Continuing Education Activities 2024
Below is a list of key Cat II CME's completed from Aug2023-Aug2024
AMA Category I
Aug 2023-2024
Herbal Medications: An Evidence-Based Review
10 hours 04/25/2024
94924
Animal-Related Health Risks
15 hours 04/24/2024
95300
Substance Use Disorders and Pain Management: MATE Act Training
8 Hours 04/20/2024
92074
Care of the Pediatric Trauma Patient
15 Hours 04/19/2024
97471
Human Trafficking and Exploitation: The Texas Requirement
5Hours 04/19/2024
40943
Acute Coronary Syndrome
15Hours 4/11-4/15/29024
95074
Antibiotics Review
5Hours 4/14-15/2024
91983
The Role of Spirituality in Health and Mental Health
5
04/01/2024
AMA Cat II
Aug 2023-2024
28Aug2024 Flanagin A, Frey T, Christiansen S, Bibbins-Domingo K. Draft Guidance on Reporting Gender, Sex, Gender Identity, Sexual Orientation, and Age in Medical and Scientific Publication—Call for Review and Comment. JAMA. 2024;332(8):e2416646. doi:10.1001/jama.2024.16646 60 min
02June2024 Article NCBI “Vitamin D Deficiency”, Sizar,O et. Al. 40min
02June2024 Tutorial Article “How to read a head CT scan” traumatic injury detection. New York Presbyterian. Perron, A. 60 min
02Jun2024 Web sources various, ‘Review of DTR’s and scoring guidelines’. 30 min
02-03Jun 2024 Textbook: “Manual of Traumatic Brain Injury. 3rd ed. Springer Publishing Company. Zollman,F.S. ed. 2022. Chapter 71 Resources for Traumatic Brain Injury Survivors and Caregivers. 60 min
Texas Asthma Control Plan 2021-2024. Texas Department of State Health Services (DSHS). 70 min
03Jun2024 Santoro,N et al. The Menopause Transition: Signs, Symptoms, and Management Options. The Journal of Clinical Endocrinology & Metabolism, 2021. Vol 106, No. 1, 1-15. 60min
25May2024 Auron,M et al. Pediatric Hospital Medicine. A High-Value Approach. Wolter Kluwer2025.
Chapter 16; Acute Asthma 95-103.
Chapter 49. Safety Planning in Mental Health. 299-314 30 min
09May2024 Thompson,WR and Ozemek,C eds. American College of Sports Medicine Clinical Exercise Physiology 2ed. Wolter Kluwer. Philadelphia 2025. Chapter 5. Cardiovascular Disease 142-226 65 min
20April2024 Ismayl,M et al. Mavacamten Treatment for Hypertrophic Cardiomyopathy: A Systemic Review and Meta-Analysis of Randomized Controlled Trials. Current Problems in Cardiology. V49. Issue 1,
January2023. Elsevier 70 min
20April2024 Bishev,D et al. Efficacy and Safety of Mavacamten in the Treatment of Hypertrophic Cardiomyopathy: A Systemic Review. Heart, Lung, and Circulation (2023) 32,1049-1056 60 min
25April2024 European Medicines Agency. Human regulatory: Overview Herbal Medicinal Products. www.ema.europa.eu/en/human-regulatory-overview/herbal-medicinal-products. Accessed 25April2024
40 min
25April2024 (Germany) Federal Institute for Drugs and Medical Devices; Committee for Medicinal Products for Human Use (CHMP) Meeting Highlights for March 2024. 45 min
15Mar2024 First, MB ed et al. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. DSM-5-TR. American Psychiatric Association Publishing. Washington, DC. 2022. Chapter Bipolar and Related Disorders 139-176. 60min
15Mar2024 National Health Service. “Treatment- Borderline Personality Disorder”. https://www.nhs.uk/mental-health/conditions/borderline-personality-disorder/overview. Accessed
15Mar2024. 20min
20Mar2024 Jay J. and Jay D. “Saving Lives, Saving Families: A Look at Family Intervention. http://lovefirst.net. Accessed 20Mar2024
15min
09Feb2024 American Osteopathic Association. “Your guide to osteopathic billing and coding resources. https://osteopathic.org/ practicing-medicine/business-of-medicine/osteopathic-billing-coding/. Accessed 09Feb2024 60 min
09Feb2024 Nong,Y et al. Expanding the Psoriasis Framework: Immunopathogenesis and Treatment Updates. www.MDEDGE.com/Dermatology. VOL113 NO2.
February 2024. 82-91. 45 min
Nov 2023 Hoefgen et.al. Pediatric asthma treatment approach with corticosteroid use in the ER, single dose dexamethasone.
30 min
Aug 2023 Dyer, J.M. and Foy, V.M. Revealing the Unseen: A Review of Wood’s Lamp in Dermatology. J Clin Aesthet Dermatol. 2022; 15(6);
25-30 Aug 2023 Martins, C. et. al . Vitiligo Skin T Cells Are Prone to Produce Type I and Type 2 Cytokines to Induce Melanocyte Dysfunction and Epidermal Inflammatory Response Through Jak Signaling. Journal of Investigative Dermatology (2022), Volume 142. Pgs 1194-1205. 60 min